Migraines that continue despite medication may signal more than treatment failure. Medication overuse, overlooked triggers, an incomplete treatment plan, or the need for preventive therapy can all keep headaches coming back.
Highlights:
- Persistent migraines should prompt a treatment review rather than an automatic increase in medication
- Frequent use of acute headache medicines can contribute to medication-overuse headache and perpetuate the cycle
- CGRP-targeting therapies are now considered a first-line option for migraine prevention, alongside established treatments
A migraine that keeps returning despite medication can leave you wondering whether treatment has stopped working. But persistent headaches do not automatically mean you need another pill or a stronger dose. Sometimes the problem is not treatment failure, but an overlooked cause, medication overuse, poor sleep, or an incomplete treatment plan.
Why do Migraines Keep Happening Despite Medication?
When headaches continue despite treatment, the first question should be whether the diagnosis is still correct. Migraine is diagnosed mainly from your symptoms and medical history, because there is no single blood test or brain scan confirming it. Other headache disorders and certain medical conditions can mimic migraine or make existing headaches worse. A treatment review is therefore often more useful than simply adding another medicine.
Some warning signs should prompt medical evaluation rather than routine migraine management. These include a sudden, extremely severe headache, progressive worsening, fever, seizures, new neurological symptoms, or unusual visual changes. A new headache after age 50, or one occurring with cancer, immune suppression or pregnancy, also deserves careful assessment. For people with a typical migraine pattern and normal neurological examination, routine brain imaging is generally unnecessary.
Could Painkillers be Causing more Headaches?
One of the most easily missed explanations is medication-overuse headache. When headaches become frequent, it is understandable to reach for painkillers or migraine medicines more often. Unfortunately, frequent use of acute headache medication can create a cycle where headaches lead to medication, temporary relief and then more headaches. The medicine intended to control the problem can sometimes become part of the problem.
According to the International Classification of Headache Disorders, medication-overuse headache involves headaches occurring at least 15 days monthly in someone with an existing headache disorder (1). The overused acute medication must generally be taken regularly for more than three months. The medication threshold varies, with triptans, opioids and combination analgesics generally reaching the threshold at 10 days monthly. Simple analgesics such as paracetamol or NSAIDs have a 15-day monthly threshold.
What Other Factors can make Migraines Worse?
Migraines rarely exist in isolation, and the surrounding health picture can influence how difficult they are to control. Depression, anxiety, chronic stress and poor sleep occur more commonly among people with migraine and can worsen its overall burden. Sleep deprivation, irregular sleep schedules, skipped meals, dehydration and excessive caffeine may also trigger attacks in susceptible people (2). Treating these factors is part of migraine care, not a dismissal of the headache as psychological.
A headache diary can make this hidden pattern easier to see. Record headache days, severity, duration, associated symptoms, menstrual timing, medicines taken and possible triggers. Over time, this information can help distinguish a consistent pattern from something that only appears to be a trigger. It can also help your doctor decide whether prevention needs to be changed or intensified.
Why Your Migraine Treatment May Need a Rethink
A preventive treatment may sometimes be called unsuccessful before it has received a fair trial. The dose may have been too low, the treatment may have been stopped too soon, or side effects may have made consistent use difficult. The choice should consider your other medical conditions, age, pregnancy considerations, lifestyle and treatment preferences. One failed preventive medicine does not mean that every preventive treatment will fail.
The migraine treatment landscape has also changed considerably. The American Headache Society now considers CGRP-targeting therapies a first-line option for migraine prevention, alongside established preventive approaches, without requiring patients to fail several older treatments first (3). These include CGRP monoclonal antibodies such as erenumab, fremanezumab, galcanezumab and eptinezumab, along with oral gepants including atogepant and rimegepant.
What Treatments are Available for Difficult-to-Treat Migraine?
For people with chronic migraine, onabotulinumtoxinA, commonly known as Botox, remains an established preventive option (4). Chronic migraine is defined as headache on at least 15 days each month for more than three months, with migraine features on at least eight days monthly. Non-invasive neuromodulation devices are another possibility for selected patients. These devices use electrical or magnetic stimulation to influence nerves or brain regions involved in migraine pathways (5).
The American Headache Society’s updated position reflects substantial evidence supporting CGRP-targeting therapies for migraine prevention. The 2024 statement found evidence for their efficacy, tolerability and safety substantial across multiple therapies, with serious adverse events uncommon. Importantly, the Society describes these medicines as a first-line option, rather than saying every patient should receive them before other treatments (6).
What This Means People who have Repeated Migraines
If migraines continue despite medication, do not assume that you simply need stronger treatment. Start by reviewing the diagnosis, medication frequency, sleep, stress, hydration, meals and other medical conditions with your doctor. A headache diary can provide valuable information that is difficult to remember during a consultation. The goal is to find why the migraine remains uncontrolled before deciding what should change.
Most importantly, difficult-to-treat migraine does not mean that nothing more can be done. Modern migraine-specific therapies have expanded the options available when conventional approaches are inadequate or poorly tolerated. Your neurologist can determine whether medication overuse, another condition, inadequate preventive treatment or a different therapy could explain the ongoing headaches. Persistent migraine deserves reassessment, not resignation.
Frequently Asked Questions
Why am I still getting migraines after taking medication?
Persistent migraines can result from an incorrect diagnosis, medication overuse, untreated triggers, associated conditions or an inadequate preventive treatment plan.
Can taking too many painkillers cause headaches?
Yes, regular overuse of certain acute headache medicines can cause medication-overuse headache in people with an existing headache disorder.
Do I need an MRI if my migraines keep returning?
Not necessarily, because routine brain imaging is generally unnecessary when the migraine pattern is typical, and the neurological examination is normal.
What are CGRP medicines for migraine?
CGRP-targeting medicines are migraine-specific preventive treatments that include monoclonal antibodies and oral medicines called gepants.
When should I see a doctor urgently for a headache?
Seek urgent medical assessment for a sudden severe headache, progressive worsening, seizures, fever, new neurological symptoms or unusual visual changes.
References:
- Headache attributed to a substance or its withdrawal
(https://ichd-3.org/8-headache-attributed-to-a-substance-or-its-withdrawal/8-2-medication-overuse-headache-moh/) - Analytical cross-sectional study on lifestyle factors associated with chronic migraine frequency
(Kalsariya SR, Palaniappan A, Saoji A, I S Kumar S, Relhan J. Analytical cross-sectional study on lifestyle factors associated with chronic migraine frequency. Bioinformation. 2025 Aug 31;21(8):2922-2926. doi: 10.6026/973206300212922. PMID: 41393474; PMCID: PMC12697497.) - CGRP-Targeting Therapies as a First-Line Option for Migraine Prevention
(https://americanheadachesociety.org/research/library/cgrp-targeting-therapies-as-a-first-line-option-for-migraine-prevention) - Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review
(Shaterian N, Shaterian N, Ghanaatpisheh A, Abbasi F, Daniali S, Jahromi MJ, Sanie MS, Abdoli A. Botox (OnabotulinumtoxinA) for Treatment of Migraine Symptoms: A Systematic Review. Pain Res Manag. 2022 Mar 31;2022:3284446. doi: 10.1155/2022/3284446. PMID: 35401888; PMCID: PMC8989603.) - Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications
(Cocores AN, Smirnoff L, Greco G, Herrera R, Monteith TS. Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications. Curr Pain Headache Rep. 2025 Feb 15;29(1):47. doi: 10.1007/s11916-024-01314-7. PMID: 39954214; PMCID: PMC11829934.) - American Headache Society Position Statement: Calcitonin Gene-Related Peptide (CGRP) Inhibitors should now be considered a first-line option for migraine prevention
(https://www.migrainedisorders.org/ahs-statement-cgrp/)
Source-Medindia